ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Formulation Brings GSK To Singapore

by Jean-François Tremblay
April 15, 2013 | APPEARED IN VOLUME 91, ISSUE 15

GlaxoSmithKline has signed a five-year agreement with a government-sponsored research agency in Singapore to create new drug formulations for sale in emerging markets. The new formulations may involve combining several existing drugs in one pill, introducing new routes of delivery, or improving safety profiles. GSK’s partner in Singapore, the Institute of Chemical & Engineering Sciences, is a member of A*STAR, a Singapore government agency that promotes scientific development in the city-state.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment